Evidence map›Paper›PMID 27040368›Full record

ArticleScientific reports2016

Phylogenetic analysis of β-xylanase SRXL1 of Sporisorium reilianum and its relationship with families (GH10 and GH11) of Ascomycetes and Basidiomycetes.

Jorge Álvarez-Cervantes, Gerardo Díaz-Godínez, Yuridia Mercado-Flores, Vijai Kumar Gupta, Miguel Angel Anducho-Reyes

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Harnessing Xylanase Potential inJournal of fungi (Basel, Switzerland) · 2025
    Article
  3. β-Xylosidase SRBX1 Activity fromJournal of fungi (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jorge Álvarez-CervantesUniversidad Politécnica de Pachuca. Zempoala, Hidalgo, México.
Gerardo Díaz-GodínezLaboratory of Biotechnology, Research Center for Biological Sciences, Universidad Autónoma de Tlaxcala, Tlaxcala, México.
Yuridia Mercado-FloresUniversidad Politécnica de Pachuca. Zempoala, Hidalgo, México.
Vijai Kumar GuptaMolecular Glycobiotechnology Group, Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland.
Miguel Angel Anducho-ReyesUniversidad Politécnica de Pachuca. Zempoala, Hidalgo, México.
Universidad Politécnica de Pachuca · MXAutonomous University of Tlaxcala · MXOllscoil na Gaillimhe – University of Galway · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, the amino acid sequence of the β-xylanase SRXL1 of Sporisorium reilianum, which is a pathogenic fungus of maize was used as a model protein to find its phylogenetic relationship with other xylanases of Ascomycetes and Basidiomycetes and the information obtained allowed to establish a hypothesis of monophyly and of biological role. 84 amino acid sequences of β-xylanase obtained from the GenBank database was used. Groupings analysis of higher-level in the Pfam database allowed to determine that the proteins under study were classified into the GH10 and GH11 families, based on the regions of highly conserved amino acids, 233-318 and 180-193 respectively, where glutamate residues are responsible for the catalysis.

Indexed as

AscomycotaBasidiomycotaConserved SequenceEndo-1,4-beta XylanasesEvolution, MolecularFungal ProteinsModels, MolecularPhylogenyProtein Structure, TertiarySequence Analysis, ProteinStructure-Activity RelationshipEndo-1,4-beta XylanasesFungal Proteins

Identifiers

PMID27040368
PMCPMC4819176
OpenAlexW2338499905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.